当前位置:首页 - 行情中心 - 硕世生物(688399) - 财务分析 - 现金流量表

硕世生物

(688399)

  

流通市值:51.79亿  总市值:51.79亿
流通股本:8387.17万   总股本:8387.17万

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金106,262,689.99396,436,406.37292,105,131.01178,751,188.34
  收到的税费返还18,322.18387,765.27350,784.1249,891.45
  收到其他与经营活动有关的现金2,369,721.8926,217,968.6423,785,862.2215,841,458.42
  经营活动现金流入小计108,650,734.06423,042,140.28316,241,777.33194,842,538.21
  购买商品、接受劳务支付的现金33,495,013.8193,826,428.7869,672,483.5649,621,065.06
  支付给职工以及为职工支付的现金42,618,999.32167,506,784.26126,002,783.1882,334,999.02
  支付的各项税费4,335,498.6419,369,175.914,362,146.039,189,545.39
  支付其他与经营活动有关的现金30,849,199.33111,998,554.2886,779,411.5954,272,568.54
  经营活动现金流出小计111,298,711.1392,700,943.22296,816,824.36195,418,178.01
  经营活动产生的现金流量净额-2,647,977.0430,341,197.0619,424,952.97-575,639.8
二、投资活动产生的现金流量:
  收回投资收到的现金515,083,393.554,358,652,053.173,609,526,290.912,390,726,848.83
  取得投资收益收到的现金-39,950,360.79321,661.96323,629.02
  处置固定资产、无形资产和其他长期资产收回的现金净额2,064,846.561,254,463.491,139,165.76860,115.3
  收到的其他与投资活动有关的现金--1,416,802.94-
  投资活动现金流入小计517,148,240.114,399,856,877.453,612,403,921.572,391,910,593.15
  购建固定资产、无形资产和其他长期资产支付的现金34,923,978.4364,453,069.0355,390,132.4835,341,562.72
  投资支付的现金626,028,900.274,528,690,051.034,012,153,960.042,834,371,918.59
  投资活动现金流出小计660,952,878.74,593,143,120.064,067,544,092.522,869,713,481.31
  投资活动产生的现金流量净额-143,804,638.59-193,286,242.61-455,140,170.95-477,802,888.16
三、筹资活动产生的现金流量:
  取得借款收到的现金231,077,600648,044,417551,500,000404,900,000
  收到其他与筹资活动有关的现金--1,146,675.78-
  筹资活动现金流入小计231,077,600648,044,417552,646,675.78404,900,000
  偿还债务支付的现金85,000,000510,400,000332,900,000235,000,000
  分配股利、利润或偿付利息支付的现金1,816,764.43293,067,102.5290,918,633.073,554,078.71
  支付其他与筹资活动有关的现金1,113,092.46,684,222.027,401,602.382,596,916.02
  筹资活动现金流出小计87,929,856.83810,151,324.52631,220,235.45241,150,994.73
  筹资活动产生的现金流量净额143,147,743.17-162,106,907.52-78,573,559.67163,749,005.27
四、汇率变动对现金及现金等价物的影响-3,108,610.55-1,443,103.41-1,448,843.2684,913.99
五、现金及现金等价物净增加额-6,413,483.01-326,495,056.48-515,737,620.91-314,544,608.7
  加:期初现金及现金等价物余额483,513,064.12810,008,120.6810,008,120.6810,008,120.6
  期末现金及现金等价物余额477,099,581.11483,513,064.12294,270,499.69495,463,511.9
补充资料:
  净利润--41,078,454.55-3,992,614.61
  资产减值准备-39,459,781.8-8,875,990.18
  固定资产和投资性房地产折旧-48,058,767.98-24,061,207.33
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-48,058,767.98-24,061,207.33
  无形资产摊销-2,293,889.53-1,159,973.32
  长期待摊费用摊销-28,460,562.04-8,454,134.1
  处置固定资产、无形资产和其他长期资产的损失--102,432.88--329,458.59
  固定资产报废损失-3,180,301.55-13,877.86
  公允价值变动损失--47,555,955.77--24,119,828.2
  财务费用-9,146,598.2-5,140,158.69
  投资损失--6,979,477.81--3,678,436.1
  递延所得税-9,009,205.17-3,020,246.11
  其中:递延所得税资产减少-9,008,538.27-3,020,246.11
    递延所得税负债增加-666.9--
  存货的减少--8,245,468.91-6,646,044.57
  经营性应收项目的减少--44,464,772.34-35,539,325.34
  经营性应付项目的增加-48,846,698.62--67,466,454.1
  其他-365,099.47-55,902.15
  现金的期末余额-483,513,064.12-495,463,511.9
  减:现金的期初余额-810,008,120.6-810,008,120.6
  现金及现金等价物的净增加额--326,495,056.48--314,544,608.7
公告日期2026-04-302026-04-232025-10-252025-08-09
审计意见(境内)标准无保留意见
TOP↑